等待開盤 11-26 09:30:00 美东时间
-0.110
-0.30%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Roth Capital analyst Justin Clare maintains Clearway Energy (NYSE:CWEN) with a Buy and raises the price target from $39 to $40.
11-25 01:44
Navigating the current market environment has become increasingly challenging for investors, as uncertainty persists and clear forward guidance remains limited with the U.S. government shutdown. The m...
11-12 22:38
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
Roth Capital analyst Justin Clare reiterates Clearway Energy (NYSE:CWEN) with a Buy and raises the price target from $38 to $39.
11-06 01:52
Clearway Energy (CWEN) declared $0.4528/share quarterly dividend. Payable Dec. 15; for shareholders of record Dec. 1; ex-div Dec. 1. See CWEN Dividend Scorecard, Yield Chart, & Dividend Growth. More o...
11-05 21:54
Earnings Call Insights: Clearway Energy, Inc. (CWEN.A) Q3 2025 Management View CEO Craig Cornelius announced that "Clearway is well positioned to deliver on its near- and long-term growth objectives a...
11-05 15:37
Clearway Energy (NYSE:CWEN) reported quarterly earnings of $2.00 per share which beat the analyst consensus estimate of $0.51 by 295.26 percent. This is a 545.16 percent increase over earnings of $0.31 per share from the
11-05 05:04
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
今日重点评级关注:摩根大通:维持Cogent Biosciences"超配"评级,目标价从30美元升至44美元;Piper Sandler:维持Vital Energy"中性"评级,目标价从16美元升至30美元
10-22 10:10